ARKGcopytrader avatar

ARKGcopytrader
πŸ‡³πŸ‡± Multi-Strategy Processing and ETF Investor.
1 copier.

Copy Trading does not amount to investment advice. Your investments value may go up or down. Your capital is at risk.

Cash Allocation

Range

Highest Cash
September 22, 2023
Lowest Cash
November 15, 2023
Average Cash

Portfolio Diversification

Range

Most Diversified
24 instruments
January 2, 2023
Least Diversified
0 instruments
September 22, 2023
Average
7.9 instruments

Most Consistent Holdings

Top 5

avatarROG.ZU
30.82%
avatarTMO
30.82%
avatarBMY
30.82%
avatarREGN
30.82%
avatarNTLA
30.82%

Position Sizing

Analysis

Avg Largest Position
Avg Smallest Position
Size Distribution
Small (<10%)
Medium (10-20%)
Large (>20%)

Market Exposure

Analysis

Highest Exposure
November 15, 2023
Lowest Exposure
September 22, 2023
Average Exposure
30-Day Trend
Current Average
Monthly Change

Top Sectors

Top 5

Health Technology
28.68%
ETFs
0.96%
Health Services
0.85%
Technology Services
0.68%

Top Countries

Top 5

πŸ‡ΊπŸ‡ΈUnited States
22.25%
πŸ‡¨πŸ‡­Switzerland
5.72%
πŸ‡―πŸ‡΅Japan
2.15%
πŸ‡«πŸ‡·France
0.08%

Number of Instruments

Holdings over time

(Since January 2, 2023)

InstrumentAvg. ExposureCurrent ExposureTime HoldingLast Closed
nsoemersnsoemers
27.37%0%31.41%8/12/2024
JinnevinkJinnevink
17.53%85.85%19.66%-
RegeneronRegeneron (REGN)
4.96%0%30.82%9/21/2023
VertexVertex (VRTX)
3.67%0%30.82%9/21/2023
NovartisNovartis (NVS)
2.92%0%30.82%9/21/2023
TakedaTakeda (TAK)
2.15%0%30.82%9/21/2023
RocheRoche (ROG.ZU)
2.1%0%30.82%9/21/2023
Exact SciencesExact Sciences (EXAS)
1.84%0%30.82%9/21/2023
IonisIonis (IONS)
1.83%0%30.82%9/21/2023
IncyteIncyte (INCY)
1.72%0%30.82%9/21/2023
SareptaSarepta (SRPT)
1.44%0%30.82%9/21/2023
Thermo FisherThermo Fisher (TMO)
1.14%0%30.82%9/21/2023
Bristol-Myers SquibbBristol-Myers Squibb (BMY)
1.11%0%30.82%9/21/2023
SPDR Bloomberg Barclays 1-3 Month T-Bill ETFSPDR Bloomberg Barclays 1-3 Month T-Bill ETF (BIL)
0.96%0%0.96%11/22/2023
Pacific BiosciencesPacific Biosciences (PACB)
0.92%0%30.82%9/21/2023
CRISPR TherapeuticsCRISPR Therapeutics (CRSP)
0.7%0%30.82%9/21/2023
VeevaVeeva (VEEV)
0.68%0%30.82%9/21/2023
TeladocTeladoc (TDOC)
0.59%0%30.82%9/21/2023
Arcturus TherapeuticsArcturus Therapeutics (ARCT)
0.56%0%30.82%9/21/2023
IntelliaIntellia (NTLA)
0.55%0%30.82%9/21/2023
VeracyteVeracyte (VCYT)
0.49%0%30.82%9/21/2023
10X Genomics10X Genomics (TXG)
0.29%0%30.82%9/21/2023
Guardant HealthGuardant Health (GH)
0.21%0%30.82%9/21/2023
Fate TherapeuticsFate Therapeutics (FATE)
0.11%0%30.82%9/21/2023
EditasEditas (EDIT)
0.1%0%30.82%9/21/2023
Cellectis SACellectis SA (CLLS)
0.08%0%30.82%9/21/2023
Invitae CorpInvitae Corp (NVTAQ)
0.05%0%30.82%9/21/2023

Exposure over time

Exposure by Sector

Exposure by Country

Portfolio Time Machine

Portfolio date
InstrumentInvestedValue
JinnevinkJinnevink
89.35%90.12%

Cash Exposure Over Time

Cash Exposure % Over Time